Content developed and sponsored by Novartis Pharmaceuticals Corporation
This content focuses on exploring variations in retinal thickness and current thinking on what this tells us about disease pathophysiology and progression. These expert interviews discuss retinal thickness in neovascular age-related macular edema (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) and what the current understanding is regarding anatomic and visual function associations.
Diana Do, MD
Arshad M. Khanani, MD
This content is intended for US health care professionals.
This presentation will not include discussion of any specific treatment and will remain focused on disease state.
This presentation is sponsored by Novartis Pharmaceuticals Corporation, and the presenters are being compensated for their time.